Article in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Shannon Esher RighiDepartment of Microbiology & Immunology, Tulane University School of Medicine, New Orleans, Louisiana, USA.ORCID 0000-0001-5212-0432
Elizabeth A LillyDepartment of Microbiology & Immunology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Amanda J HarriettDepartment of Microbiology & Immunology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Patrick W DalyDepartment of Microbiology & Immunology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
MaryJane JonesDepartment of Microbiology & Immunology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Chad SteeleDepartment of Microbiology & Immunology, Tulane University School of Medicine, New Orleans, Louisiana, USA.ORCID 0000-0001-5655-4596
Mairi C Noverr *Department of Microbiology & Immunology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Paul L Fidel *Center of Excellence in Oral and Craniofacial Biology, Louisiana State University Health School of Dentistry, New Orleans, Louisiana, USA.ORCID 0000-0001-8066-5763
Funding
Candida mediated protection against polymicrobial sepsisR01AI145096 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI FIDEL, PAUL L, STEELE, CHAD · 2019 to 2023
$2.9M
Fungal-bacterial dynamics driving dysregulated host responses and lethal synergismR01AI177615 · NIAID · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI JAMES E CASSAT, PAUL L FIDEL · 2024 to 2026
Trained immunity is a long-term functional reprogramming of innate cells that allows for the formation of immune memory akin to adaptive responses, but with a more rapid nonspecific response. We recently identified an anti-inflammatory trained immunity response, termed trained tolerogenic immunity (TTI), induced by low virulence
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Induction of myelopoiesis by · full record | OpenQuestion